• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Bachem

    CMC Pharmaceuticals

    Almac Group

    LOTTE BIOLOGICS

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Bachem

    CMC Pharmaceuticals

    Almac Group

    LOTTE BIOLOGICS

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Portola Pharmaceuticals R&D Exec to Retire

    Pamela Conley will lead research efforts on an interim basis

    Related CONTENT
    • Softweb Solutions
    • GW Pharmaceuticals Appoints CCO
    • Triphase Accelerator Initiates Phase I Trial of TRPH-222
    • MTPA, Massachusetts General Hospital Embark on ALS Study
    • Orchard Therapeutics Adds CTO Role
    04.24.19
    Portola Pharmaceuticals, Inc.: Dr. John Curnutte, M.D., Ph.D., executive vice president and head of R&D, will retire on May 17, 2019, after more than eight years of service. Dr. Curnutte will remain in a consultancy role, providing guidance to Portola’s president and chief executive officer Scott Garland and engaging with key academic and scientific thoughtleaders in the field on the ongoing development of Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo] and cerdulatinib.

    On an interim basis, the company’s research efforts will be led by Pamela Conley, Ph.D., senior vice president of Research, who has contributed to the discovery and development of Portola’s portfolio for more than 15 years. The company expects to name a permanent Chief Medical Officer following an executive search. During the transition, Portola’s vice president of Medical Affairs, Jeff Myers, M.D., Ph.D., will serve as interim chief medical officer. Dr. Myers is a former pediatric cardiac surgeon with extensive experience leading Medical Affairs for a number of large biotech and pharmaceutical companies, including Gilead Sciences, Inc. and Genzyme.
     
    “On behalf of the entire Portola team, I would like to thank John for shepherding Portola’s unique portfolio of potentially life-saving medicines through various stages of development and regulatory approval, and for his unwavering commitment to patients,” said Mr. Garland. “John leaves behind a significant legacy of scientific accomplishment and we are grateful that the Company will continue to benefit from his guidance and counsel while he shifts his primary focus to spending more time with his family and grandchildren.”

    Dr. Curnutte said, “I am incredibly fortunate to have worked with such talented and passionate individuals, and to have had the opportunity to advance several truly innovative compounds with the potential to transform patient outcomes. I look forward to continuing to raise awareness and understanding of the clinical benefits of Andexxa while also helping to expand its potential to benefit even more patients.”
    Related Searches
    • chief executive officer
    • executive vice president
    • R&D
    • gilead
    Suggested For You
    Softweb Solutions Softweb Solutions
    GW Pharmaceuticals Appoints CCO GW Pharmaceuticals Appoints CCO
    Triphase Accelerator Initiates Phase I Trial of TRPH-222  Triphase Accelerator Initiates Phase I Trial of TRPH-222
    MTPA, Massachusetts General Hospital Embark on ALS Study MTPA, Massachusetts General Hospital Embark on ALS Study
    Orchard Therapeutics Adds CTO Role Orchard Therapeutics Adds CTO Role
    Personalized Medicine: Getting More Out of Clinical Trials Personalized Medicine: Getting More Out of Clinical Trials
    Sanofi Appoints Chief Digital Officer Sanofi Appoints Chief Digital Officer
    Polyphor Awarded $5.6M Grant from CARB-X Polyphor Awarded $5.6M Grant from CARB-X
    Lonza Supplies Portola’s Second-Gen Andexxa Lonza Supplies Portola’s Second-Gen Andexxa
    Alkermes Announces Grant Recipients Alkermes Announces Grant Recipients
    Syneos Health Names Clinical Solutions President Syneos Health Names Clinical Solutions President
    Biogen Expands Neurological Disease R&D Biogen Expands Neurological Disease R&D
    Oncolytics Biotech Appoints CMO Oncolytics Biotech Appoints CMO
    Sun Pharma Acquires Pola Pharma in Japan Sun Pharma Acquires Pola Pharma in Japan
    Altasciences Expands Bioanalytical Lab  Altasciences Expands Bioanalytical Lab

    Related Buyers Guide Companies

    • Softweb Solutions

      ...
      Micheal Jury, Marketing Manager 09.23.20

    • Bio News | Industry News | Promotions & Moves
      GW Pharmaceuticals Appoints CCO

      GW Pharmaceuticals Appoints CCO

      Mr. Darren Cline is an accomplished biopharmaceutical executive with over 25 years of commercial experience
      04.12.19

    • Breaking News | Industry News
      Triphase Accelerator Initiates Phase I Trial of TRPH-222

      Triphase Accelerator Initiates Phase I Trial of TRPH-222

      Next-Gen Antibody-Drug Conjugate developed using Catalent’s SMARTag ADC Technology
      04.01.19


    • Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      MTPA, Massachusetts General Hospital Embark on ALS Study

      MTPA, Massachusetts General Hospital Embark on ALS Study

      Hospital's Neurological Clinical Research Institute will help to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis
      03.29.19

    • Promotions & Moves
      Orchard Therapeutics Adds CTO Role

      Orchard Therapeutics Adds CTO Role

      Zheng will oversee process development, manufacturing, quality, facilities and engineering, supply chain, and CMC program management
      03.18.19

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login